OpenNeedle Ask your own

Question explored with the scientific record

What's the evidence on statins and muscular pain?

Nov 16, 2026 · 6 sources used · OpenNeedle synthesis
The short version: statins really do cause muscle pain in some people, but the honest trial evidence is smaller and messier than either side admits.

The best evidence here is STOMP, a randomized, double-blind, placebo-controlled trial in 420 healthy, statin-naive people. Protocol-defined myalgia hit 19 of 203 on atorvastatin versus 10 of 217 on placebo, about 9 in 100 versus 5 in 100, and the difference just missed statistical significance [3][5]. Reanalyzing with dropouts included pushed the p-value to 0.08 [5]. That is a real signal in the right direction, not proof. The trial was young, healthy people treated six months, so it cannot tell you about a 70-year-old on a high dose for a decade [5].

The messier truth is in GAUSS-3. Among people who already blamed statins for muscle pain, 42.6% got symptoms on atorvastatin only, but 26.5% got them on placebo only, and 17.3% got them on neither [5]. A large share of "statin myalgia" is not the statin. Meanwhile a review of 44 statin trials found only one actually asked about muscle symptoms [5], so the trial literature was never built to count this harm.

GroupMuscle painNotes
STOMP atorvastatin19/203 (9.4%)p=0.054 [3][5]
STOMP placebo10/217 (4.6%)[3][5]
GAUSS-3 atorvastatin only209 (42.6%)presumed-sufferers [5]
GAUSS-3 placebo only130 (26.5%)[5]
GAUSS-3 neither85 (17.3%)[5]

Dose matters. In 192 statin users, myalgia was common but did not differ between high and moderate doses, though that study had no non-statin control [1]. A Korean cohort found 7% reporting new muscle pain on atorvastatin, but only 3.4% meeting criteria for probable statin-related myalgia [2]. Risk factors include advanced age, female sex, small body frame, high dose, and drug interactions [4]. CoQ10 has not worked in a meta-analysis of 10 studies [5], and vitamin D trials including VITAL showed no benefit [6].

My call: statin muscle pain is real for a minority and dose-related, but many who blame statins are mistaken, and the trials were never designed to measure it well. Confidence: moderate.

Keep digging

Sources used 6

  1. Myalgia in Patients on High‐Dose and Low‐to‐Moderate Dose Statin Therapy Journal of Pharmacy Practice and Research (2009) primary study Strong

    In 192 statin users, myalgia was common but did not differ significantly between high-dose and low-to-moderate dose groups, and analgesic use and self-reported adherence were similarly not different.

    DOI: 10.1002/j.2055-2335.2009.tb00453.x
  2. A Prospective Single-Center Study of Incidence of Atorvastatin-Induced Myalgia in Korean Patients: Application of the Statin Myalgia Clinical Index Journal of the Korean Neurological Association (2022) primary study Strong

    In 89 Korean dyslipidemia patients, 6 (7%) reported new unexplained muscle pain on atorvastatin, but only 3.4% (3/87) met SMCI criteria for possible or probable atorvastatin-associated myalgia.

    DOI: 10.17340/jkna.2022.1.3
  3. Effect of Statins on Skeletal Muscle Function Circulation (2013) Thin

    The STOMP study investigates the effects of atorvastatin on muscle performance and the incidence of muscle complaints in healthy, statin-naive individuals, finding no significant impact on muscle strength or exercise capacity, but an increased incidence of myalgia associated wit…

    DOI: 10.1161/circulationaha.112.136101
  4. Narrative Review: Statin-Related Myopathy Annals of Internal Medicine (2009) Thin

    This narrative review synthesizes current knowledge on statin-related myopathy, detailing definitions, mechanisms, epidemiology, clinical features, risk factors, management strategies, and emerging pharmacogenetic and adjunctive treatment data.

    DOI: 10.7326/0003-4819-150-12-200906160-00009
  5. What to Believe and Do About Statin-Associated Adverse Effects JAMA (2016) commentary Strong

    This Viewpoint argues that statins' vascular benefits outweigh their rare adverse effects, but clinicians should acknowledge, investigate, and collaboratively manage statin-associated muscle symptoms despite ongoing uncertainty about mild myalgia.

    DOI: 10.1001/jama.2016.16557
  6. Statin-Associated muscle symptoms and vitamin D supplementation Current Opinion in Cardiology (2025) narrative review Strong

    This narrative review examines evidence on vitamin D supplementation for statin-associated muscle symptoms (SAMS), finding observational data suggest benefit while large randomized clinical trials, including VITAL, show no benefit in preventing SAMS or reducing statin discontinu…

    DOI: 10.1097/hco.0000000000001222

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →